mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study

Authors

Document Type

Journal Article

Publication Date

4-1-2022

Journal

The Journal of pediatrics

Volume

243

DOI

10.1016/j.jpeds.2021.12.025

Keywords

mRNA COVID-19 vaccine-associated myopericarditis; outcomes; survey; variability

Abstract

In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.

Department

Pediatrics

Share

COinS